Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood.

Q3 2025 Results Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsCorey Davis - Investor Relations, ...

Populations in low-resource countries are experiencing greater impacts and have less capacity to adapt in the future. Respiratory effects range from direct heat and air pollution effects ...

More severe exposure can lead to respiratory complications. Some ozone therapy procedures involve blowing gas into the body. If an individual receives ozone therapy via the rectum, they may ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on ...

Almost half (45%) of employees are unaware of their company’s EAP, 38% find existing services irrelevant, and 63% believe AI could replace traditional therapy for most employees by 2030. Future ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of its achievements in 2024 and outlining its 2025 plans.